Advances in Hematology / 2017 / Article / Tab 3

Research Article

Chimerism in Myeloid Malignancies following Stem Cell Transplantation Using FluBu4 with and without Busulfan Pharmacokinetics versus BuCy

Table 3

Total donor chimerism on day 100.

Chimerism results at day 100P value
FluBu4 with PKFluBu4 with no PKBuCy

100% donor141317.006
86%–99%3120
<85%496

Bu, busulfan; Cy, cyclophosphamide; Flu, fludarabine; PK, pharmacokinetics.